2 Surefire Ways to Invest in SpaceX Now (and After) Its Historic IPO

SpaceX is reportedly preparing for an IPO as early as June 12, with a target valuation around $1.75 trillion to $2 trillion. The article highlights existing exposure through Ark Venture Fund, where SpaceX is about 11% of assets, and Baron funds, where it represents roughly 25% to 29% of holdings. The piece is broadly upbeat on SpaceX’s growth and listing prospects, but it is primarily informational and unlikely to move markets immediately.

Analysis

The investable winner here is not the eventual IPO buyer, but the pre-IPO holders that have effectively turned SpaceX into a mark-to-market call option on late-stage private liquidity. If the listing clears anywhere near headline valuation, the immediate mechanical benefit accrues to funds with concentrated exposure because their NAV gets re-rated before most public-market investors can access the name directly. That creates a short-term feedback loop in which fund flows and secondary-market enthusiasm matter more than fundamentals for a few weeks.

The more interesting second-order effect is competitive pressure on adjacent public names. A successful mega-IPO would likely reset private-market comps for frontier-tech, which can help other venture-heavy managers and late-stage crossover vehicles, but it also raises the hurdle rate for every unprofitable growth stock claiming “category creation.” In particular, the market may rotate capital away from mature hardware/software compounders toward perceived moonshots, which is a sentiment headwind for the profitable AI infrastructure complex if the listing absorbs retail and momentum capital.

The main risk is that the trade is front-running a liquidity event, not cash flows: if the IPO is delayed, downsized, or priced with a lower free float than expected, the narrative can de-rate fast. For SOFI, the relevance is indirect but real: access rails into retail private-market products can see a short-lived volume spike, yet that benefit is fragile and likely mean-reverting once the event passes. TSLA remains the macro beta proxy because Musk-linked enthusiasm tends to spill over into his public asset, but that also means it is vulnerable to disappointment if investors decide SpaceX is a separate story rather than a platform effect.

Key Decisions for Investors

• Long ARKVX vs cash into the IPO window: use a 2-4 week tactical position for exposure to a potential pre-listing NAV uplift; target a 10-15% move, but cut quickly if filing timing slips or valuation language softens.
• Long BPTRX / BARAX on pullbacks, not breakouts: these are the cleaner ways to express the re-rating if the IPO pricing is robust; expect asymmetric upside from NAV marks, but size modestly because concentration risk cuts both ways.
• Trade TSLA as event beta, not fundamental conviction: consider a short-dated call spread into the IPO date if sentiment is still building, with defined downside if the market treats SpaceX as non-transferable to TSLA.
• Avoid chasing SOFI after a headline spike: use any post-event strength to fade the retail-access narrative, since the monetization is likely transitory unless SpaceX-linked fund flows persist for multiple quarters.
• Relative value: long venture/late-stage exposure (ARKVX or Baron funds) vs short a basket of high-multiple unprofitable growth names for 1-3 months; the IPO can compress the dispersion between “real optionality” and “story stock” exposure.